Debra Cockayne
About Debra Cockayne
Debra Cockayne is a Preclinical Research Manager II at Boston Scientific with extensive experience in inflammation and neuroscience research.
Current Role at Boston Scientific
Debra Cockayne serves as a Preclinical Research Manager II at Boston Scientific, where she has been employed since 2011. Based in San Jose, CA, her role involves overseeing preclinical research programs. Her work focuses on the management and development of research projects that are critical to the advancement of Boston Scientific’s product pipeline.
Previous Experience at Hoffmann-La Roche
Between 2009 and 2011, Debra worked at Hoffmann-La Roche in Nutley, NJ, as a Principal Research Scientist specializing in Inflammation. During her tenure, she played a key role in inflammation research, likely contributing to the company’s efforts in identifying and developing new therapeutic options.
Academic Background at University of Vermont College of Medicine
Debra Cockayne completed her Ph.D. in Biochemistry at the University of Vermont College of Medicine, from 1982 to 1987. Her academic training laid a solid foundation in biochemistry, which has significantly informed her extensive career in biomedical research and pharmacology.
Expertise in Biomarker Discovery and Drug Discovery
Debra has established expertise in biomarker discovery within the fields of inflammation and neuroscience. She is adept in preclinical drug discovery, focusing on both small molecules and biologics/bispecifics. Her skillset includes proficient handling of in vitro and in vivo pharmacological studies, along with deep knowledge in molecular and cellular biology.
Early Career at NIH and DNAX Research Institute
Debra began her scientific career at the NIH, National Heart, Lung, and Blood Institute where she worked as a Post Doctoral Fellow from 1987 to 1991. She later joined the DNAX Research Institute, serving as a Post Doctoral Fellow and Senior Research Associate from 1991 to 1996. These formative years provided her with substantial research experience and set the stage for her subsequent roles in the pharmaceutical industry.